Market Place
Sourcing Support
All News #Library
Enforcement Report - Week of June 11, 2025
11 Jun 2025 //
FDA
FDA Issues Form 483 to Torrent Pharmaceuticals
26 Jun 2024 //
FDA
FDA Issues Form 483 to Torrent Pharmaceuticals Limited
28 Dec 2023 //
FDA
Torrent Pharmaceuticals Limited on Health Canada Inspection List
05 Jun 2023 //
HEALTH CANADA
FDA Issues Form 483 to Torrent Pharmaceuticals Limited
18 Oct 2022 //
FDA
Enforcement Report - Week of May 11, 2022
11 May 2022 //
PRESS RELEASE
Enforcement Report - Week of January 19, 2022
19 Jan 2022 //
FDA
Enforcement Report - Week of December 22, 2021
22 Dec 2021 //
FDA
Enforcement Report - Week of December 9, 2020
09 Dec 2020 //
FDA
Enforcement Report - Week of June 10, 2020
10 Jun 2020 //
FDA
Torrent Pharma Receives FDA Warning Letter
19 Nov 2019 //
FDA
Torrent Pharmaceuticals Limited Receives FDA Warning Letter
15 Oct 2019 //
FDA
Enforcement Report - Week of October 9, 2019
09 Oct 2019 //
FDA
Enforcement Report - Week of September 25, 2019
26 Sep 2019 //
FDA
Enforcement Report - Week of May 8, 2019
08 May 2019 //
FDA
Torrent Pharmaceuticals Receives FDA Form 483
03 May 2019 //
FDA
Enforcement Report - Week of April 17, 2019
17 Apr 2019 //
FDA
Enforcement Report - Week of February 27, 2019
27 Feb 2019 //
FDA
Torrent Pharmaceuticals Recalls Losartan Potassium and Losartan/HCTZ Tablets
23 Jan 2019 //
FDA
Torrent Pharmaceuticals Expands Recall of Losartan Potassium Tablets
04 Jan 2019 //
FDA
Torrent Pharmaceuticals Recalls Losartan Potassium Tablets
21 Dec 2018 //
FDA
Valsartan products under recall - Updated November 27, 2018
28 Nov 2018 //
FDA
Enforcement Report - Week of September 26, 2018
26 Sep 2018 //
FDA
FDA provides update on its ongoing investigation into valsartan products
13 Sep 2018 //
FDA
Enforcement Report - Week of September 5, 2018
05 Sep 2018 //
FDA
US FDA Issues Form 483 to Torrent Pharmaceuticals Limited
11 May 2017 //
FDA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.